NovoLog (insulin aspart) and Humalog (insulin lispro) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in certain ...

The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...

Humalog is given as an injection, and there are two types of the drug: Some forms of Humalog and Humalog Mix are available as generics or biosimilars. To learn more, see “Generic or biosimilar ...

The Food and Drug Administration (FDA) has approved Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL [U-200]; Eli Lilly) to improve glycemic control in patients with type 1 and type 2 ...

Eli Lilly, a major U.S.-based drugmaker, has issued a warning regarding a shortage of insulin medication in Canada, which is expected to persist through mid-April. The 10-millilitre vials of the ...

U.S. Sen. Bernie Sanders and Rep. Cori Bush introduced a bill that would limit the list price of insulin at $20 per vial, the latest effort to force drugmakers to lower the cost of the life-saving ...

--- Positive opinion could lead to first 200 units/ml rapid-acting insulin in Europe for the treatment of type 1 and type 2 diabetes INDIANAPOLIS, July 30, 2014 /PRNewswire/ -- Eli Lilly and Company ...

--- First 200 units/ml rapid-acting insulin product for the treatment of diabetes INDIANAPOLIS, Oct. 3, 2014 /PRNewswire/ -- Eli Lilly and Company today announced that the European Commission has ...